Ir al contenido
· Rellenos dérmicos
SKU 10481

HArmonyCa Lidocaine

En stock
Volumen
2 x 125 mL
Laboratorio
Allergan Aesthetics
Origen
Francia
Indicación
Facial soft tissue augmentation; dual-action rejuvenation
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

Principales ventajas de HArmonyCa Lidocaine

  • Provides an immediate lifting and volumising effect through hyaluronic acid
  • Supports sustained collagen stimulation through calcium hydroxyapatite
  • Combines hyaluronic acid and calcium hydroxyapatite in one ready-to-use injectable
  • Designed for facial soft tissue augmentation in the deep dermal and sub-dermal layers
  • Contains 0.3% lidocaine hydrochloride to reduce pain during treatment
  • Supplied as two 1.25 mL pre-filled syringes with two 27G thin-wall needles
  • CE-marked medical device
Información clave
Marca HARMONYCA
Fabricante Allergan Aesthetics
País de origen France
Certificación CE-marked medical device; filled syringe CE 2409, needle CE 0123
Composición Calcium hydroxyapatite microspheres 25-45 microns (55.7%); cross-linked sodium hyaluronate gel 20 mg/mL; phosphate buffer; lidocaine hydrochloride 3 mg/mL (0.3%)
Envase 2 pre-filled syringes x 1.25 mL, with 2 single-use 27G 1/2" thin-wall sterile needles
Tamaño de la aguja 27G 1/2" thin-wall needles supplied; 25G or 27G thin-wall if a needle replacement is needed
Tipo de uso Professional use only - sterile, biodegradable injectable facial implant; single use, single patient
Profundidad de inyección Deep dermal and sub-dermal layers

Indicaciones y uso profesional

Indicaciones principales

  • Facial soft tissue augmentation
  • Deep dermal and sub-dermal facial volume augmentation

Uso profesional

For use only by authorised medical practitioners in accordance with local regulation, under sterile conditions, following clinical assessment. Single use, single patient; do not re-sterilise. Insert at approximately 30 degrees into the deep dermis with the bevel oriented downwards, using a linear threading technique, and cross-hatching in layers where larger volumes are required. Aspirate before injecting. Subsequent treatments may be required, with at least seven days between treatments to allow evaluation of the outcome, and at least four weeks between ultrasound-based, laser or peeling treatments and use of this product. It is contraindicated in pregnancy or breastfeeding, in patients under 18, in patients with known sensitivity to any product component or to lidocaine or other amide-type local anaesthetics, and in patients with conditions for which lidocaine is contraindicated. It is also contraindicated in skin disease or abnormal skin conditions, acute or chronic infection or inflammation at or near the treatment site, susceptibility to keloid or hypertrophic scarring, impaired wound healing, prolonged bleeding, a history of anaphylaxis or multiple severe allergies, known sensitivity to steroids, herpes, and autoimmune disease. It must not be injected into the glabellar or periocular areas, the lips or perioral region, regions containing foreign bodies, blood vessels or highly vascularised areas, or the epidermis or superficial dermis.

Zonas de tratamiento

  • Mid and lower face
  • Cheek lines
  • Lower-face contour and sagginess
  • Skin firmness

Perfil del paciente

Patients aged 18 years or older who are suitable for facial soft tissue augmentation following clinical assessment by an authorised medical practitioner. Contraindicated during pregnancy and breastfeeding, and in patients meeting the other exclusion criteria, including known sensitivity to any product component or to amide-type local anaesthetics. Safety and efficacy have not been evaluated in diabetic patients, in patients previously treated with other filling implants, or in patients with a history of keloid formation, connective tissue disease, active bleeding disorders, active hepatitis, cancer, stroke or myocardial infarction, or on immunosuppressive therapy.

Cómo funciona HArmonyCa Lidocaine ​

HArmonyCa combines cross-linked hyaluronic acid and calcium hydroxyapatite in a single injectable. The hyaluronic acid component provides an immediate lifting and volumising effect, while the calcium hydroxyapatite microspheres, at 25 to 45 microns and 55.7% of the formulation, support sustained collagen stimulation and provide progressive structural support after treatment. The 0.3% lidocaine hydrochloride reduces pain during treatment. The implant is placed in the deep dermal and sub-dermal layers and is biodegradable.

Por qué comprar en Allpara

Allpara ofrece productos HARMONYCA originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

What is in HArmonyCa?

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.

How does HArmonyCa differ from a standard hyaluronic acid filler?

HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.

How often can HArmonyCa be repeated?

Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
HARMONYCA
Laboratorio
Allergan Aesthetics
SKU
10481
Formato
2 x 125 mL
Origen
Francia
Indicación
Facial soft tissue augmentation; dual-action rejuvenation
Uso
Professional, hybrid HA/CaHA injectable
/ Detalles del producto

El expediente completo

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

Allergan Aesthetics, país de origen Francia.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

What is in HArmonyCa?

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.

How does HArmonyCa differ from a standard hyaluronic acid filler?

HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.

How often can HArmonyCa be repeated?

Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

What is in HArmonyCa?
Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.
How does HArmonyCa differ from a standard hyaluronic acid filler?
HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.
How often can HArmonyCa be repeated?
Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.
/ FAQ

Preguntas frecuentes

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.
HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.
Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

Más productos de Allergan

Ver laboratorio

Alternativas para la clínica

Todos los productos

HArmonyCa Lidocaine

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

Principales ventajas de HArmonyCa Lidocaine

  • Provides an immediate lifting and volumising effect through hyaluronic acid
  • Supports sustained collagen stimulation through calcium hydroxyapatite
  • Combines hyaluronic acid and calcium hydroxyapatite in one ready-to-use injectable
  • Designed for facial soft tissue augmentation in the deep dermal and sub-dermal layers
  • Contains 0.3% lidocaine hydrochloride to reduce pain during treatment
  • Supplied as two 1.25 mL pre-filled syringes with two 27G thin-wall needles
  • CE-marked medical device
Información clave
Marca HARMONYCA
Fabricante Allergan Aesthetics
País de origen France
Certificación CE-marked medical device; filled syringe CE 2409, needle CE 0123
Composición Calcium hydroxyapatite microspheres 25-45 microns (55.7%); cross-linked sodium hyaluronate gel 20 mg/mL; phosphate buffer; lidocaine hydrochloride 3 mg/mL (0.3%)
Envase 2 pre-filled syringes x 1.25 mL, with 2 single-use 27G 1/2" thin-wall sterile needles
Tamaño de la aguja 27G 1/2" thin-wall needles supplied; 25G or 27G thin-wall if a needle replacement is needed
Tipo de uso Professional use only - sterile, biodegradable injectable facial implant; single use, single patient
Profundidad de inyección Deep dermal and sub-dermal layers

Indicaciones y uso profesional

Indicaciones principales

  • Facial soft tissue augmentation
  • Deep dermal and sub-dermal facial volume augmentation

Uso profesional

For use only by authorised medical practitioners in accordance with local regulation, under sterile conditions, following clinical assessment. Single use, single patient; do not re-sterilise. Insert at approximately 30 degrees into the deep dermis with the bevel oriented downwards, using a linear threading technique, and cross-hatching in layers where larger volumes are required. Aspirate before injecting. Subsequent treatments may be required, with at least seven days between treatments to allow evaluation of the outcome, and at least four weeks between ultrasound-based, laser or peeling treatments and use of this product. It is contraindicated in pregnancy or breastfeeding, in patients under 18, in patients with known sensitivity to any product component or to lidocaine or other amide-type local anaesthetics, and in patients with conditions for which lidocaine is contraindicated. It is also contraindicated in skin disease or abnormal skin conditions, acute or chronic infection or inflammation at or near the treatment site, susceptibility to keloid or hypertrophic scarring, impaired wound healing, prolonged bleeding, a history of anaphylaxis or multiple severe allergies, known sensitivity to steroids, herpes, and autoimmune disease. It must not be injected into the glabellar or periocular areas, the lips or perioral region, regions containing foreign bodies, blood vessels or highly vascularised areas, or the epidermis or superficial dermis.

Zonas de tratamiento

  • Mid and lower face
  • Cheek lines
  • Lower-face contour and sagginess
  • Skin firmness

Perfil del paciente

Patients aged 18 years or older who are suitable for facial soft tissue augmentation following clinical assessment by an authorised medical practitioner. Contraindicated during pregnancy and breastfeeding, and in patients meeting the other exclusion criteria, including known sensitivity to any product component or to amide-type local anaesthetics. Safety and efficacy have not been evaluated in diabetic patients, in patients previously treated with other filling implants, or in patients with a history of keloid formation, connective tissue disease, active bleeding disorders, active hepatitis, cancer, stroke or myocardial infarction, or on immunosuppressive therapy.

Cómo funciona HArmonyCa Lidocaine ​

HArmonyCa combines cross-linked hyaluronic acid and calcium hydroxyapatite in a single injectable. The hyaluronic acid component provides an immediate lifting and volumising effect, while the calcium hydroxyapatite microspheres, at 25 to 45 microns and 55.7% of the formulation, support sustained collagen stimulation and provide progressive structural support after treatment. The 0.3% lidocaine hydrochloride reduces pain during treatment. The implant is placed in the deep dermal and sub-dermal layers and is biodegradable.

Por qué comprar en Allpara

Allpara ofrece productos HARMONYCA originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

What is in HArmonyCa?

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.

How does HArmonyCa differ from a standard hyaluronic acid filler?

HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.

How often can HArmonyCa be repeated?

Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

Más productos de Allergan

Ver el laboratorio →

HArmonyCa Lidocaine is a hybrid hyaluronic acid and calcium hydroxyapatite injectable facial implant for the Allergan Aesthetics range, intended for facial soft tissue augmentation. It is suitable for authorised medical practitioners, who place it in the deep dermal and sub-dermal layers of the mid and lower face, where the hyaluronic acid provides an immediate lifting and volumising effect and the calcium hydroxyapatite microspheres support sustained collagen stimulation, so one treatment gives both an instant result and progressive structural support. The product contains calcium hydroxyapatite microspheres of 25 to 45 microns at 55.7%, cross-linked sodium hyaluronate gel at 20 mg/mL, phosphate buffer and lidocaine hydrochloride at 3 mg/mL (0.3%) to reduce pain during treatment, and it is a CE-marked medical device for professional use by authorised medical practitioners only. It is supplied as two 1.25 mL pre-filled glass syringes with two single-use 27G half-inch thin-wall sterile needles.

Allergan Aesthetics, país de origen Francia.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

What is in HArmonyCa?

Calcium hydroxyapatite microspheres of 25 to 45 microns diameter at 55.7%, suspended in a cross-linked sodium hyaluronate gel at 20 mg/mL from a non-animal source, with a phosphate buffer and lidocaine hydrochloride at 3 mg/mL.

How does HArmonyCa differ from a standard hyaluronic acid filler?

HArmonyCa combines cross-linked hyaluronic acid for immediate volume with calcium hydroxyapatite microspheres for sustained collagen stimulation, giving it a dual mechanism that standard single-ingredient hyaluronic acid fillers do not have.

How often can HArmonyCa be repeated?

Subsequent treatments may be required to obtain optimal results, with at least seven days between treatments so the outcome of the implantation can be evaluated.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.